PATHOLOGY REFERENCE INTERVAL MASTER LIST Issue date: 9/10/2020 WIN-QS-19-2 Page 1 of 34 Monash Health Pathology This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production. Pathology Reference Interval Master List
34
Embed
New Pathology Reference Interval Master List · 2020. 10. 9. · PATHOLOGY REFERENCE INTERVAL MASTER LIST Issue date: 9/10/2020 WIN-QS-19-2 Page 3 of 34 Monash Health Pathology This
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 1 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Pathology Reference Interval Master List
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 2 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Table of Contents Chemical Pathology ......................................................................................................................................................... 3
Reference intervals for blood gas analysis (Radiometer) .......................................................................................... 17
Reference intervals for blood gas analysis (i-STAT) ................................................................................................... 18
A ratio of >70 should be confirmed by a repeat ratio after 3 days of salt loading of 2-3g with each meal plus a 24h urine
for aldosterone and sodium excretion. NOTE: Antihypertensive medications may alter this ratio.
ALDOSTERONE EXCRETION – 24h urine
nmol/d
3 – 78 3 – 78 08/05/2014
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 4 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age Value Age Value
ALKALINE PHOSPHATASE (ALP), serum
U/L <28d 80 - 550 <28d 80 - 550
20/07/2018
28d to <6m 120 - 650 28d to <6m 120 - 650
6m to <2y 120 - 450 6m to <2y 120 - 450
2 to <6y 120 - 370 2 to <6y 120 - 370
6 to <10y 120 - 440 6 to <10y 120 - 440
10 to <14y 130 - 530 10 to <14y 130 - 530
14 to <15y 105 - 480 14 to <15y 105 - 480
15 to <17y 80 - 380 15 to <17y 80 - 380
17 to <19y 50 - 220 17 to <19y 50 - 220
19 to <22y 45 - 150 19 to <22y 45 - 150
>22 y 30 - 110 >22 y 30 - 110
ALANINE AMINOTRANSFERASE (ALT), serum
U/L 5 - 40 5 - 35 29/11/2017
AMIKACIN – PRE-DOSE, serum mg/L
Interpretation of gentamicin levels must be done with assistance of the hospital Pharmacists and infection control Physicians. Additional caution is required in the presence of
renal impairment.
– POST-DOSE, serum
AMMONIA umol/L 16 - 50 16 - 50 30/11/2017
AMYLASE, serum U/L 30 - 100 30 - 100
ANTI MULLERIAN HORMONE (AMH), Serum
pmol/L 0 - 13d 250 - 1040 0 to <2m 1 - 24
14d to <6m 420 - 1470 2m to <1y 4 - 30
6m to 2y 680 - 2330 1y to <5y 3 - 40
2y to 9y 240 - 1830 5y to <25y 7 - 50
9y to 18y 30 - 1370 25 to <30y 10 - 45 >18y 25 - 140 30 to <35y 4 - 45 08/07/2016 35y to <40y 1 - 37
22/05/2013 20y to <50y 1.2 – 2.5 20y to <50y 1.2 – 2.5
≥ 50y 1.4 – 3.2 ≥ 50y 1.4 – 3.2
BICARBONATE, serum mmol/L <2y 15 - 29 <2y 15 - 29
04/12/2017 2y to <10yr 17 - 30 2y to <10yr 17 - 30
10 to <18y 20 - 32 10 to <18y 20 - 32
≥18y 22 - 32 ≥18y 22 - 32
BILIRUBIN TOTAL, serum umol/L 0d <150 0d <150
13/12/2017
1d to <3d < 200 1d to <3d < 200
3d to <30d <300 3d to <30d <300
≥30d <20 ≥30d <20
The reference intervals for neonates applies to full-term babies only. For preterm babies, please see the NICE guideline for neonatal jaundice (https://www.nice.org.uk/guidance/cg98)
BILIRUBIN – CONJUGATED, serum
umol/L <28d <10 <28d <10 13/12/2017
13/12/2017
≥28d <5 ≥28d <5
BILIRUBIN – UNCONJUGATED, serum
umol/L ≥28d <15 ≥4wk <15
BRAIN NATRIURETIC PEPTIDE (BNP)
ng/L 0 - 100 0 - 100
CAERULOPLASMIN, serum g/L 0 to <2m 0.07 – 0.24 0 to <2m 0.07 – 0.24
18/07/2018
2m to <6m 0.14 – 0.33 2m to <6m 0.14 – 0.33
6m to <1y 0.14 – 0.39 6m to <1y 0.14 – 0.39
1y to <8y 0.22 – 0.43 1y to <8y 0.22 – 0.43
8y to <14y 0.21 – 0.40 8y to <14y 0.21 – 0.40
14y to <19y 0.22 – 0.43 14y to <19y 0.22 – 0.43
≥19y 0.22 – 0.58 ≥19y 0.22 – 0.58
CALCIUM, CORRECTED, serum
mmol/L <7 days 1.85 – 2.80 <7 days 1.85 – 2.80 19/10/2017 7d to <6m 2.20 – 2.80 7d to <6m 2.20 – 2.80
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age Value Age Value
CORTISOL, serum mmol/L 185 - 625 185 - 625
This reference interval applies to AM cortisol. PM cortisol levels are approximately 50% lower. Note: A random or AM cortisol has limited value in excluding adrenal insufficiency.
Monitoring target: <7.0% (53 mmol/mol). Different targets may be required for pregnancy, elderly, people at high risk of hypoglycaemia and those with CVD or severe comorbidities.
Diagnostic cutoff: Greater than or equal to 6.5% (48 mmol/mol) (MJA 2012;197:1)
For paediatrics:
Monitoring target: <7.5% (58 mmol/mol)
For young pre-school children at risk of hypoglycaemia, a higher Hba1c target of <8.0% (64 mmol/mol) is acceptable
(MJA 2011;195:45)
Diagnostic cut off: Greater than or equal to 6.5% (48 mmol/mol) (MJA 2012:197:1)
03/08/2018
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 10 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age Value Age Value
HAPTOGLOBIN g/L <15d 0 – 0.1 <15d 0 – 0.1
24/04/2018
15d to <1y 0.07 – 2.21 15d to <1y 0.07 – 2.21
1y to <12y 0.07 – 1.63 1y to <12y 0.07 – 1.63
12y to <19y 0.07 – 1.79 12y to <19y 0.07 – 1.79
>19y 0.36 – 1.95 >19y 0.36 – 1.95
HCG QUANTITATIVE, serum
IU/L <1 <40y <1
28/11/2017
40y to <55y <3
≥55y <12
Values 2-25 IU/L are equivocal for pregnancy, suggest repeat after 2 days to confirm.
Total PSA ug/L <4.0 Free PSA ug/L When total PSA is 4-10
ug/L, a free/total PSA ratio <10% indicates approximately 57% risk of prostate cancer, while a free/total PSA ratio >25% indicates approximately 12% risk of prostate cancer.
TACROLIMUS ug/L Consult the hospital Pharmacists and renal transplant Physicians
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 15 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age Value Age Value
TESTOSTERONE-LCMS, serum
nmol/L <7d 0.2 – 2.7 <7d 0.1 – 2.7
16/07/2018
7d to <3m 0.5 – 12.6 7d to <7y 0.1 – 0.8
3m to <6m 0.1 – 3.1 7y to <10y 0.1 – 1.0
6m to <10y 0.1 – 0.8 >10y 0.1 – 1.7
10y to <13y 0.1 – 5.6
13y to <16y 0.7 – 17.6
16y to <18y 4.0 – 24.0
18y to <40y 10.0 – 27.6
>40y 10.0 – 25.0
THIOCYANATE, serum mmol/L 0.10 – 0.50 0.10 – 0.50
Pre 2000
NOTE: The reference interval quoted is for Nitroprusside therapy.
Toxic level: >0.86 mmol/L
THYROGLOBULIN, serum
ug/L
1.6 – 50 1.6 – 50
28/11/2017
In post thyroidectomy patient with a history of thyroid cancer, serial determinations are required and should be
reference to the post surgical baseline. Thyroglobulin >1ug/L is suspicious of residual or recurrent disease.
Intact thyroid: thyroglobulin reference range 1.6 – 50ug/L. Presence of anti-thyroglobulin antibody can give a variable
negative interference in the thyroglobulin result.
THYROTROPIN (TSH), serum
mIU/L 0d 4.1 – 40.2 0d 4.1 – 40.2
28/12/2017
1d 3.2 – 29.6 1d 3.2 – 29.6
2d 2.6 – 17.3 2d 2.6 – 17.3
3d 2.2 – 14.7 3d 2.2 – 14.7
4d 1.8 – 14.2 4d 1.8 – 14.2
5d 1.4 – 12.7 5d 1.4 – 12.7
6d - 14d 1.1 – 8.3 6d - 14d 1.1 – 8.3
15d - 90d 0.9 – 7.1 15d - 90d 0.9 – 7.1
91d to <1y 0.6 – 4.8 91d to <1y 0.6 – 4.8
>1y 0.4 – 4.8 >1y 0.4 – 4.8
TOBRAMYCIN, serum PEAK level THROUGH level RANDOM spot level
mg/L mg/L mg/L
Interpretation of tobramycin levels must be done with assistance of the hospital Pharmacists and infection control Physicians. Additional caution is required in
Interpretation of vancomycin levels must be done with assistance of the hospital Pharmacists and infection control Physicians. Additional caution is required in
the presence of renal impairment.
ZINC, plasma umol/L 12 – 20 12 – 20 05/03/2018
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 17 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Reference intervals for blood gas analysis (Radiometer)
Test Unit Arterial or Capillary
Venous Date
implemented
pH mmHg 7.35 – 7.45 7.32 – 7.43
pO2 mmHg 83 – 108 15 – 64
pCO2 mmol/L 32 – 45 38 – 61
Bicarbonate 22 – 32 22 – 32
Base Excess mmol/L -3 – +3 -3 – +3
Sodium mmol/L 135 – 145 135 – 145
Potassium mmol/L 3.5 – 5.2 3.5 – 5.2
Chloride mmol/L 95 – 110 95 – 110
Calcium-Ionized mmol/L 1.15 – 1.33 1.15 – 1.33
Lactate mmol/L 0.5 – 2.0 0.5 – 2.0
Glucose (random) umol/L 3.0 – 7.7 3.0 – 7.7
Creatinine (Adult) mmol/L 60 – 110 (M)
45 – 90 (F)
60 – 110 (M)
45 – 90 (F)
Bilirubin (adult) mmHg 0 – 20 0 – 20
Oxyhaemoglobin % 90 – 95 n/a
Methaemoglobin (MetHb), % 0 – 2 0 – 2
Carboxyhaemoglobin (COHb), non-smoker
% 0 – 2 0 – 2
p50 mmHg <7 days 19 – 24
≥7 days 25 - 31
<7 days 19 – 24
≥7 days 25 - 31
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 18 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Reference intervals for blood gas analysis (i-STAT)
Test Unit Arterial or Capillary Venous Date
implemented
Sodium mmol/L <7d: 132 – 147
7d to <18y: 133 – 144
≥18y: 135 – 145
<7d: 132 – 147
7d to <18y: 133 –144
≥18y: 135 – 145
Potassium mmol/L <7d: 3.5 – 6.2
7d to 6m: 3.8 – 6.4
2y to 18y: 3.3 – 4.9
≥18y: 3.5 – 5.2
<7d: 3.5 – 6.2
7d to 6m: 3.8 – 6.4
2y to 18y: 3.3 – 4.9
≥18y: 3.5 – 5.22
Chloride mmol/L 95 – 110 95 – 110
Calcium-Ionized mmol/L 1.15 – 1.33 1.15 – 1.33
Lactate mmol/L 0.5 – 2.0 0.5 – 2.0
Glucose (random) umol/L 3.0 – 7.7 3.0 – 7.7
Creatinine (Adult) mmol/L <7d: 22 – 93
7d to 27d: 17 – 50
28d to 2y: 11 – 36
2y to <6y: 20 – 44
6y to <12y: 27 – 58
12 to 15y: 35 – 83
15y to 19y: 50 – 100
≥19y: 60 - 110(M); 45 - 90(F)
<7d: 22 – 93
7d to 27d: 17 – 50
28d to 2y: 11 – 36
2y to <6y: 20 – 44
6y to <12y: 27 – 58
12 to 15y: 35 – 83
15y to 19y: 50 – 100
≥19y: 60 – 110(M); 45 - 90(F)
pH mmHg 7.35 – 7.45 7.32 – 7.43
pO2 mmHg 83 – 108 15 – 64
pCO2 mmol/L 32 – 45 38 – 61
Bicarbonate 22 – 32 22 – 32
Base Excess mmol/L -3 – +3 -3 – +3
Oxygen saturation (O2 sat)
% 95 – 98 n/a
Troponin I (iSTAT) ug/L 0 – 0.04 0 – 0.04
Haemoglobin (blood gas)
0-3d g/L 135 – 230 135 – 230
4-6d g/L 135 – 210 135 – 210
7-13d g/L 125 – 205 125 – 205
14-30d g/L 115 – 190 115 – 190
30d to <3m g/L 100 – 180 100 – 180
3m to <6m g/L 95 – 135 95 – 135
6m to <2y g/L 100 – 140 100 – 140
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 19 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Arterial or Capillary Venous Date
implemented
2 to <13y * g/L 115 – 150 115 – 150
13 to <56y g/L 130 – 180 (M)
120 – 160 (F)
130 – 180 (M)
120 – 160 (F)
≥56years g/L 125 – 175 (M)
110 – 160 (F)
125 – 175 (M)
110 – 160 (F)
* Note: Hb reference interval for age 2 to <6y: 115 – 150 g/L; and for age 6y to <13y: 115-155 g/L have been merged into one group as the Radiometer can fit maximum 10 categories for each analyte.
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 20 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Haematology
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
FBE – WHITE CELL COUNT
x10^9/L 0 d 13.0-37.0 0 d 13.0-37.0
1-3 d 9.0-30.0 1-3 d 9.0-30.0
4-6 d 5.0-18.0 4-6 d 5.0-18.0
7-13 d 5.0-18.0 7-13 d 5.0-18.0
14.-30 d 5.0-18.0 14.-30 d 5.0-18.0
1-2 m 5.0-18.0 1-2 m 5.0-18.0
3-5 m 5.0-18.0 3-5 m 5.0-18.0
6-24 m 5.0-18.0 6-24 m 5.0-18.0
2-5 y 5.0-15.0 2-5 y 5.0-15.0
6-12 y 5.0-15.0 6-12 y 5.0-15.0
13-55 y 4.0-11.0 13-55 y 4.0-11.0
>55 y 4.0-11.0 >55 y 4.0-11.0
PREGNANT 4.5-17.0
FBE – RED CELL COUNT
x10^12/L 0 d 3.9-6.2 0 d 3.9-6.2
1-3 d 3.9-6.2 1-3 d 3.9-6.2
4-6 d 3.9-6.2 4-6 d 3.9-6.2
7-13 d 3.6-6.1 7-13 d 3.6-6.1
14.-30 d 3.6-5.7 14.-30 d 3.6-5.7
1-2 m 3.0-5.6 1-2 m 3.0-5.6
3-5 m 3.0-4.6 3-5 m 3.0-4.6
6-24 m 3.7-5.3 6-24 m 3.7-5.3
2-5 y 3.9-5.3 2-5 y 3.9-5.3
6-12 y 4.0-5.2 6-12 y 4.0-5.2
13-55 y 4.5-6.2 13-55 y 3.8-5.4
>55 y 4.2-6.2 >55 y 3.7-5.4
PREGNANT 3.6-5.4
FBE – HAEMOGLOBIN g/L 0 d 135-230 0 d 135-230
1-3 d 135-230 1-3 d 135-230
4-6 d 135-210 4-6 d 135-210
7-13 d 125-205 7-13 d 125-205
14.-30 d 115-190 14.-30 d 115-190
1-2 m 100-180 1-2 m 100-180
3-5 m 95-135 3-5 m 95-135
6-24 m 100-140 6-24 m 100-140
2-5 y 115-150 2-5 y 115-150
6-12 y 115-155 6-12 y 115-155
13-55 y 130-180 13-55 y 120-160
>55 y 125-175 >55 y 110-160
PREGNANT 105-160
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 21 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
FBE – HAEMATOCRIT L/L 0 d 0.40-0.70 0 d 0.40-0.70
1-3 d 0.40-0.70 1-3 d 0.40-0.70
4-6 d 0.40-0.70 4-6 d 0.40-0.70
7-13 d 0.38-0.65 7-13 d 0.38-0.65
14.-30 d 0.34-0.60 14.-30 d 0.34-0.60
1-2 m 0.30-0.55 1-2 m 0.30-0.55
3-5 m 0.27-0.46 3-5 m 0.27-0.46
6-24 m 0.30-0.44 6-24 m 0.30-0.44
2-5 y 0.33-0.46 2-5 y 0.33-0.46
6-12 y 0.33-0.47 6-12 y 0.33-0.47
13-55 y 0.38-0.54 13-55 y 0.35-0.48
>55 y 0.37-0.53 >55 y 0.34-0.48
PREGNANT 0.33-0.48
FBE – MEAN CELL VOLUME
fl 0 d 95-130 0 d 95-130
1-3 d 95-130 1-3 d 95-130
4-6 d 88-130 4-6 d 88-130
7-13 d 85-110 7-13 d 85-110
14.-30 d 85-110 14.-30 d 85-110
1-2 m 76-110 1-2 m 76-110
3-5 m 74-108 3-5 m 74-108
6-24 m 70-90 6-24 m 70-90
2-5 y 75-90 2-5 y 75-90
6-12 y 77-96 6-12 y 77-96
13-55 y 78-98 13-55 y 78-98
>55 y 78-98 >55 y 78-98
PREGNANT 78-102
FBE – MEAN CELL HAEMOGLOBIN
pg 0 d 31.0-37.0 0 d 31.0-37.0
1-3 d 31.0-37.0 1-3 d 31.0-37.0
4-6 d 28.0-38.0 4-6 d 28.0-38.0
7-13 d 28.0-38.0 7-13 d 28.0-38.0
14.-30 d 28.0-38.0 14.-30 d 28.0-38.0
1-2 m 26.0-34.0 1-2 m 26.0-34.0
3-5 m 25.0-35.0 3-5 m 25.0-35.0
6-24 m 23.0-31.0 6-24 m 23.0-31.0
2-5 y 24.0-31.0 2-5 y 24.0-31.0
6-12 y 25.0-33.0 6-12 y 25.0-33.0
13-55 y 27.0-34.0 13-55 y 27.0-34.0
>55 y 27.0-34.0 >55 y 27.0-34.0
PREGNANT 27.0-34.0
FBE – MEAN CELL HAEMOGLOBIN CONC
g/L ALL 310-355 ALL 310-355
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 22 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
FBE – RED CELL DISTRIBUTION WIDTH
% ALL 11.0-15.0 ALL 11.0-15.0
FBE – PLATELETS x10^9/L 0 d 100-500 0 d 100-500
1-3 d 100-500 1-3 d 100-500
4-6 d 100-500 4-6 d 100-500
7-13 d 100-500 7-13 d 100-500
14.-30 d 150-450 14.-30 d 150-450
1-2 m 150-450 1-2 m 150-450
3-5 m 150-450 3-5 m 150-450
6-24 m 150-450 6-24 m 150-450
2-5 y 150-450 2-5 y 150-450
6-12 y 150-450 6-12 y 150-450
13-55 y 150-450 13-55 y 150-450
>55 y 150-450 >55 y 150-450
PREGNANT 150-450
FBE –MEAN PLATELET VOLUME
fl ALL 6.5-120 ALL 6.5-12.0
FBE – RETICULOCYTES
%
% 0 d 2.0-7.0 0 d 2.0-7.0
1-3 d 2.0-6.0 1-3 d 2.0-6.0
4-7 d 2.0-4.5 4-7 d 2.0-4.5
1-4 w 0.0-2.0 1-4 w 0.0-2.0
> 4 w 0.3-2.5 > 4 w 0.3-2.5
FBE – RETICULOCYTES ABSOLUTE
x10^9/L 0 d 100-300 0 d 100-300
1-3 d 100-300 1-3 d 100-300
4-7 d 100-250 4-7 d 100-250
1-4 w 0-100 1-4 w 0-100
> 4 w 20-110 > 4 w 20-110
FBE – NEUTROPHILS x10^9/L 0 d 3.20-18.00 0 d 3.20-18.00
1-3 d 4.50-17.00 1-3 d 4.50-17.00
4-6 d 2.00-9.50 4-6 d 2.00-9.50
7-13 d 2.00-9.50 7-13 d 2.00-9.50
14-30 d 2.00-9.50 14-30 d 2.00-9.50
1-2 m 1.50-9.50 1-2 m 1.50-9.50
3-5 m 1.50-9.00 3-5 m 1.50-9.00
6-24 m 1.50-9.00 6-24 m 1.50-9.00
2-5 y 1.50-8.00 2-5 y 1.50-8.00
6-12 y 1.50-8.00 6-12 y 1.50-8.00
>13 y 2.00-8.00 >13 y 2.00-8.00
PREGNANT 3.60-15.00
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 23 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
FBE – LYMPHOCYTES x10^9/L 0 d 3.00-8.50 0 d 3.00-8.50
1-3 d 3.00-8.50 1-3 d 3.00-8.50
4-6 d 3.00-8.50 4-6 d 3.00-8.50
7-13 d 3.00-8.50 7-13 d 3.00-8.50
14-30 d 3.00-8.50 14-30 d 3.00-8.50
1-2 m 2.00-8.00 1-2 m 2.00-8.00
3-5 m 2.00-8.00 3-5 m 2.00-8.00
6-24 m 2.00-8.00 6-24 m 2.00-8.00
2-5 y 1.50-7.00 2-5 y 1.50-7.00
6-12 y 1.50-7.00 6-12 y 1.50-7.00
>13 y 1.00-4.00 >13 y 1.00-4.00
PREGNANT 1.00-4.00
FBE - MONOCYTES
x10^9/L 0 d 0.20-4.00 0 d 0.20-4.00
1-3 d 0.20-4.00 1-3 d 0.20-4.00
4-6 d 0.20-2.00 4-6 d 0.20-2.00
7-13 d 0.20-2.00 7-13 d 0.20-2.00
14-30 d 0.20-1.00 14-30 d 0.20-1.00
1-2 m 0.20-1.00 1-2 m 0.20-1.00
3-5 m 0.20-1.00 3-5 m 0.20-1.00
6-24 m 0.20-1.00 6-24 m 0.20-1.00
2-5 y 0.20-1.00 2-5 y 0.20-1.00
6-12 y 0.20-1.00 6-12 y 0.20-1.00
>13 y 0.20-1.00 >13 y 0.20-1.00
PREGNANT 0.20-1.00
FBE- EOSINOPHILS x10^9/l 0 d 0.00-2.00 0 d 0.00-2.00
1-3 d 0.00-2.00 1-3 d 0.00-2.00
4-6 d 0.00-2.00 4-6 d 0.00-2.00
7-13 d 0.00-2.00 7-13 d 0.00-2.00
14-30 d 0.00-2.00 14-30 d 0.00-2.00
1-2 m 0.00-1.00 1-2 m 0.00-1.00
3-5 m 0.00-1.00 3-5 m 0.00-1.00
6-24 m 0.00-1.00 6-24 m 0.00-1.00
2-5 y 0.00-1.00 2-5 y 0.00-1.00
6-12 y 0.00-1.00 6-12 y 0.00-1.00
>13 y 0.00-0.50 >13 y 0.00-0.50
PREGNANT 0.00-0.5
FBE – BASOPHILS x10^9/L ALL 0.00-0.20 ALL 0.00-0.2
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 24 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
FBE – BAND FORMS x10^9/L 0 d 0.00-1.30 0 d 0.00-1.30
1-3 d 0.00-1.30 1-3 d 0.00-1.30
4-6 d 0.00-1.30 4-6 d 0.00-1.30
7-13 d 0.00-1.30 7-13 d 0.00-1.30
14-30 d 0.00-1.30 14-30 d 0.00-1.30
1-2 m 0.00-0.85 1-2 m 0.00-0.85
3-5 m 0.00-0.85 3-5 m 0.00-0.85
6-24 m 0.00-0.85 6-24 m 0.00-0.85
2-5 y 0.00-0.85 2-5 y 0.00-0.85
6-12 y 0.00-0.85 6-12 y 0.00-0.85
>13 y 0.00-0.85 >13 y 0.00-0.85
PREGNANT 0.00-0.85
FBE –NUCLEATED RBC /100 WC 0 d 0-9 0 d 0-9
1-3 d 0-9 1-3 d 0-9
4-6 d 0-7 4-6 d 0-7
7-13 d 0-4 7-13 d 0-4
>14 d 0-0 >14 d 0-0
PREGNANT 0-0
ERYHROCYTE SEDIMENTATION RATE
mm in 1 hr
0-3 d 0-2 0-3 d 0-2
4d – 12 y 0-7 4d – 12 y 0-7
13-55 y 0-10 13-55 y 0-15
>55 y 0-15 >55 y 0-25
PREGNANT 0-35
AUTOHAEMOLYSIS with added glucose (glucose)
% ALL 0.0-0.9 ALL 0.0-0.9
AUTOHAEMOLYSIS without added glucose (no glucose)
% ALL 0.2-2.0 ALL 0.2-2.0
G6PD ASSAY U/gHb ALL 11.0-18.0 ALL 11.0-18.0
NEUTROPHIL ALKALINE PHOSPATASE
SCORE ALL 13-130 ALL 13-130
HB ELECTROPHORESIS- HbA2 LEVEL
% 0- d 2.0-3.3 0- d 2.0-3.3
1d-1m 2.0-3.3 1d-1m 2.0-3.3
1m-2m 2.0-3.3 1m-2m 2.0-3.3
2m-3m 2.0-3.3 2m-3m 2.0-3.3
3m-4m 2.0-3.3 3m-4m 2.0-3.3
4m-6m 2.0-3.3 4m-6m 2.0-3.3
>6m 2.0-3.3 >6m 2.0-3.3
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 25 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
HB ELECTROPHORESIS – HbF lEVEL
% 0- 1d 70.0-90.0 0- d 70.0-90.0
1d-1m 50.0-75.0 1d-1m 50.0-75.0
1m-2m 25.0-60.0 1m-2m 25.0-60.0
2m-3m 10.0-35.0 2m-3m 10.0-35.0
3m-4m 5.0-20.0 3m-4m 5.0-20.0
4m-6m 0.0-8.0 4m-6m 0.0-8.0
>6m 0.0-1.0 >6m 0.0-1.0
HB ELECTROPHORESIS- Hb S QUANT
% 0- d 0.0-0.0 0- d 0.0-0.0
1d-1m 0.0-0.0 1d-1m 0.0-0.0
1m-2m 0.0-0.0 1m-2m 0.0-0.0
2m-3m 0.0-0.0 2m-3m 0.0-0.0
3m-4m 0.0-0.0 3m-4m 0.0-0.0
4m-6m 0.0-0.0 4m-6m 0.0-0.0
>6m 0.0-0.0 >6m 0.0-0.0
COAGULATION – International Normalised Ratio
ratio 0-1d 1.0-1.4 0-1d 1.0-1.4
2d-5d 1.0-1.4 2d-5d 1.0-1.4
6d-1m 1.0-1.3 6d-1m 1.0-1.3
2m-3m 0.8-1.2 2m-3m 0.8-1.2
4m-6m 0.8-1.2 4m-6m 0.8-1.2
>6m 0.8-1.2 >6m 0.8-1.2
COAGULATION – Activated Partial Thromboplastin Time
sec 0-1d 22-60 0-1d 22-60
2d-5d 22-50 2d-5d 22-50
6d-1m 22-50 6d-1m 22-50
2m-3m 22-50 2m-3m 22-50
4m-6m 22-45 4m-6m 22-45
>6m 22-32 >6m 22-32
COAGULATION – Fibrinogen
g/L 0-1d 1.5-4.5 0-1d 1.5-4.5
2d-5d 1.5-4.5 2d-5d 1.5-4.5
6d-1m 1.5-4.0 6d-1m 1.5-4.0
2m-3m 1.5-4.0 2m-3m 1.5-4.0
4m-6m 1.5-4.0 4m-6m 1.5-4.0
>6m 1.5-4.0 >6m 1.5-4.0
COAGULATION- Fibrinogen Clauss
g/L 0-1d 1.5-4.5 0-1d 1.5-4.5
2d-5d 1.5-4.5 2d-5d 1.5-4.5
6d-1m 1.5-4.0 6d-1m 1.5-4.0
2m-3m 1.5-4.0 2m-3m 1.5-4.0
4m-6m 1.5-4.0 4m-6m 1.5-4.0
>6m 1.5-4.0 >6m 1.5-4.0
COAGULATION- Thrombin Clotting Time
sec ALL 10.0-20.0 ALL 10.0-20.0
COAGULATION – Ddimer
mg/L ALL 0.00-0.20 ALL 0.00-0.20
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 26 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
COAGULATION – Echis Time
sec ALL 20-26 ALL 20-26
COAGULATION – FACTOR 2 LEVEL
IU/mL 0-1d 0.25-0.65 0-1d 0.25-0.65
2d-5d 0.30-0.80 2d-5d 0.30-0.80
6d-1m 0.30-1.00 6d-1m 0.30-1.00
2m-3m 0.40-1.00 2m-3m 0.40-1.00
4m-6m 0.60-1.2 4m-6m 0.60-1.2
>6m 0.60-1.50 >6m 0.60-1.50
COAGULATION – FACTOR 5 LEVEL
IU/mL 0-1d 0.30-1.00 0-1d 0.30-1.00
2d-5d 0.40-1.40 2d-5d 0.40-1.40
6d-1m 0.60-1.45 6d-1m 0.60-1.45
2m-3m 0.60-1.50 2m-3m 0.60-1.50
4m-6m 0.60-1.50 4m-6m 0.60-1.50
>6m 0.60-1.50 >6m 0.60-1.50
COAGULATION –FACTOR 7 LEVEL
IU/mL 0-1d 0.30-1.00 0-1d 0.30-1.00
2d-5d 0.35-1.00 2d-5d 0.35-1.00
6d-1m 0.40-1.35 6d-1m 0.40-1.35
2m-3m 0.45-1.35 2m-3m 0.45-1.35
4m-6m 0.50-1.35 4m-6m 0.50-1.35
>6m 0.65-1.35 >6m 0.65-1.35
COAGULATION –FACTOR 8 LEVEL
IU/mL 0-1d 0.90-2.00 0-1d 0.90-2.00
2d-5d 0.70-1.80 2d-5d 0.70-1.80
6d-1m 0.60-1.50 6d-1m 0.60-1.50
2m-3m 0.50-1.50 2m-3m 0.50-1.50
4m-6m 0.50-1.50 4m-6m 0.50-1.50
>6m 0.50-1.50 >6m 0.50-1.50
COAGULATION –FACTOR 9 LEVEL
IU/mL 0-1d 0.20-0.90 0-1d 0.20-0.90
2d-5d 0.15-0.90 2d-5d 0.15-0.90
6d-1m 0.20-0.80 6d-1m 0.20-0.80
2m-3m 0.20-1.30 2m-3m 0.20-1.30
4m-6m 0.40-1.30 4m-6m 0.40-1.30
>6m 0.60-1.40 >6m 0.60-1.40
COAGULATION –FACTOR 10 LEVEL
IU/mL 0-1d 0.15-0.70 0-1d 0.15-0.70
2d-5d 0.20-0.80 2d-5d 0.20-0.80
6d-1m 0.30-0.85 6d-1m 0.30-0.85
2m-3m 0.30-1.00 2m-3m 0.30-1.00
4m-6m 0.50-1.10 4m-6m 0.50-1.10
>6m 0.60-1.30 >6m 0.60-1.30
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 27 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
COAGULATION –FACTOR 11 LEVEL
IU/mL 0-1d 0.10-0.60 0-1d 0.10-0.60
2d-5d 0.20-0.90 2d-5d 0.20-0.90
6d-1m 0.30-0.80 6d-1m 0.30-0.80
2m-3m 0.40-1.00 2m-3m 0.40-1.00
4m-6m 0.50-1.30 4m-6m 0.50-1.30
>6m 0.65-1.35 >6m 0.65-1.35
COAGULATION –FACTOR 12 LEVEL
U/mL 0-1d 0.10-0.90 0-1d 0.10-0.90
2d-5d 0.10-0.80 2d-5d 0.10-0.80
6d-1m 0.15-0.80 6d-1m 0.15-0.80
2m-3m 0.20-1.10 2m-3m 0.20-1.10
4m-6m 0.40-1.20 4m-6m 0.40-1.20
>6m 0.65-1.50 >6m 0.65-1.50
COAGULATION –FACTOR 13 LEVEL
U/mL 0-1d 0.30-1.00 0-1d 0.30-1.00
2d-5d 0.30-1.00 2d-5d 0.30-1.00
6d-1m 0.50-1.40 6d-1m 0.50-1.40
2m-3m 0.70-1.40 2m-3m 0.70-1.40
4m-6m 0.70-1.40 4m-6m 0.70-1.40
>6m 0.70-1.40 >6m 0.70-1.40
COAGULATION – Von Willebrand Factor Ag
IU/mL 0-1d 0.90-3.00 0-1d 0.90-3.00
2d-5d 0.70-2.80 2d-5d 0.70-2.80
6d-1m 0.60-2.60 6d-1m 0.60-2.60
2m-3m 0.50-2.40 2m-3m 0.50-2.40
4m-6m 0.50-2.20 4m-6m 0.50-2.20
>6m 0.50-2.00 >6m 0.50-2.00
COAGULATION – Collagen Binding Assay
IU/mL 0-1d 0.90-3.00 0-1d 0.90-3.00
2d-5d 0.70-2.80 2d-5d 0.70-2.80
6d-1m 0.60-2.60 6d-1m 0.60-2.60
2m-3m 0.50-2.40 2m-3m 0.50-2.40
4m-6m 0.50-2.20 4m-6m 0.50-2.20
>6m 0.50-2.00 >6m 0.50-2.00
COAGULATION - Ristocetin Cofactor Assay
U/mL 0-1d 0.90-3.00 0-1d 0.90-3.00
2d-5d 0.70-2.80 2d-5d 0.70-2.80
6d-1m 0.60-2.60 6d-1m 0.60-2.60
2m-3m 0.50-2.40 2m-3m 0.50-2.40
4m-6m 0.50-2.20 4m-6m 0.50-2.20
>6m 0.50-2.00 >6m 0.50-2.00
COAGULATION – Antithrombin 3 Assay
IU/mL 0-1d 0.40-0.85 0-1d 0.40-0.85
2d-5d 0.45-0.90 2d-5d 0.45-0.90
6d-1m 0.50-1.05 6d-1m 0.50-1.05
2m-3m 0.60-1.15 2m-3m 0.60-1.15
4m-6m 0.70-1.20 4m-6m 0.70-1.20
>6m 0.80-1.20 >6m 0.80-1.20
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 28 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
COAGULATION – Protein C Assay
IU/mL 0-1d 0.15-0.50 0-1d 0.15-0.50
2d-5d 0.20-0.65 2d-5d 0.20-0.65
6d-1m 0.30-0.70 6d-1m 0.30-0.70
2m-3m 0.40-0.80 2m-3m 0.40-0.80
4m-6m 0.50-1.00 4m-6m 0.50-1.00
>6m 0.70-1.40 >6m 0.70-1.40
COAGULATION – Protein S Assay
IU/mL 0-1d 0.15-0.75 0-1d 0.15-0.75
2d-5d 0.25-0.90 2d-5d 0.25-0.90
6d-1m 0.40-1.20 6d-1m 0.40-1.20
2m-3m 0.55-1.50 2m-3m 0.55-1.50
4m-6m 0.55-1.50 4m-6m 0.55-1.50
>6m 0.55-1.50 >6m 0.55-1.50
COAGULATION – Activated Protein C assay
ratio 0-1d 2.1-5.0 0-1d 2.1-5.0
2d-5d 2.1-5.0 2d-5d 2.1-5.0
6d-1m 2.1-5.0 6d-1m 2.1-5.0
2m-3m 2.1-5.0 2m-3m 2.1-5.0
4m-6m 2.1-5.0 4m-6m 2.1-5.0
>6m 2.1-5.0 >6m 2.1-5.0
COAGULATION – Heparin Cofactor Assay
U/Ml 0-1d 0.20-0.90 0-1d 0.20-0.90
2d-5d 0.50-1.00 2d-5d 0.50-1.00
6d-1m 0.50-1.20 6d-1m 0.50-1.20
2m-3m 0.65-1.45 2m-3m 0.65-1.45
4m-6m 0.65-1.45 4m-6m 0.65-1.45
>6m 0.65-1.45 >6m 0.65-1.45
COAGULATION – Plasminogen Assay
U/mL 0-1d 0.20-0.60 0-1d 0.20-0.60
2d-5d 0.30-0.80 2d-5d 0.30-0.80
6d-1m 0.50-1.00 6d-1m 0.50-1.00
2m-3m 0.70-1.30 2m-3m 0.70-1.30
4m-6m 0.75-1.50 4m-6m 0.75-1.50
>6m 0.75-1.50 >6m 0.75-1.50
COAGULATION – Plasminogen Activator
ng/mL >6m 1.0-20.0 >6m 1.0-20.0
COAGULATION – Plasminogen Activator Inhibitor
U/mL >6m 0.0-3.5 >6m 0.0-3.5
COAGULATION – LA Russel Viper Venom
ratio >6m 0.8-1.2 >6m 0.8-1.2
LA Russel Viper Venom Correction
ratio >6m 0.8-1.2 >6m 0.8-1.2
LA Russel Viper Venom Mix
ratio >6m 0.8-1.2 >6m 0.8-1.2
PROTHROMBIN ANTIBODY ASSAY
U/mL >6m 0.0-10.0 >6m 0.0-10.0
BETA 2 GLYCOPROTEIN ASSAY
CU >6m 0-20 >6m 0-20
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 29 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
PROTHROMBIN FRAGMENTS 1&2
pmol/L >6m 70-230 >6m 70-230
ADAMTS-13 ASSAY % >6m 40-130 >6m 40-130
PLATELET FUNCTION TEST
Collagen % >6m 75-100 >6m 75-100
Arahidonic Acid % >6m 75-100 >6m 75-100
ADP (10uM) % >6m 75-100 >6m 75-100
ADP (5uM) % >6m 75-100 >6m 75-100
Ristocetin (1.5mg) % >6m 75-100 >6m 75-100
Ristocetin (0.5mg) % >6m 0-10 >6m 0-10
Epineperine (10umM) % >6m 75-100 >6m 75-100
Collagen/Epinepherine sec >6m 93-170 >6m 93-170
Collagen/ADP sec >6m 66-133 >6m 66-133
BONE MARROW DIFFERENTIAL (BM)
BM NEUTROPHILS % 0d 10.0-40.0 0d 10.0-40.0
1d-14d 10.0-40.0 1d-14d 10.0-40.0
15d-29d 10.0-40.0 15d-29d 10.0-40.0
1m-12m 5.0-30.0 1m-12m 5.0-30.0
12m-6y 3.8-12.0 12m-6y 3.8-12.0
7y-13y 3.8-12.0 7y-13y 3.8-12.0
>14y 3.8-12.0 >14y 3.8-12.0
BM LYMPHOCYTES % 0d 4.0-22.0 0d 4.0-22.0
1d-14d 4.0-22.0 1d-14d 4.0-22.0
15d-29d 4.0-22.0 15d-29d 4.0-22.0
1m-12m 20.0-65.0 1m-12m 20.0-65.0
12m-6y 20.0-65.0 12m-6y 20.0-65.0
7y-13y 5.0-30.0 7y-13y 5.0-30.0
>14y 8.6-23.8 >14y 8.6-23.8
BM MONOCYTES % 0d 0.0-3.0 0d 0.0-3.0
1d-14d 0.0-3.0 1d-14d 0.0-3.0
15d-29d 0.0-3.0 15d-29d 0.0-3.0
1m-12m 0.0-3.0 1m-12m 0.0-3.0
12m-6y 0.0-3.0 12m-6y 0.0-3.0
7y-13y 0.0-3.0 7y-13y 0.0-3.0
>14y 0.0-0.8 >14y 0.0-0.8
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 30 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
BM EOSINOPHILS % 0d 0.0-7.0 0d 0.0-7.0
1d-14d 0.0-7.0 1d-14d 0.0-7.0
15d-29d 0.0-7.0 15d-29d 0.0-7.0
1m-12m 0.0-5.0 1m-12m 0.0-5.0
12m-6y 1.0-6.0 12m-6y 1.0-6.0
7y-13y 1.0-6.0 7y-13y 1.0-6.0
>14y 1.1-5.3 >14y 1.1-5.3
BM BASOPHILS % 0d 0.0-0.8 0d 0.0-0.8
1d-14d 0.0-0.8 1d-14d 0.0-0.8
15d-29d 0.0-0.8 15d-29d 0.0-0.8
1m-12m 0.0-0.8 1m-12m 0.0-0.8
12m-6y 0.0-0.8 12m-6y 0.0-0.8
7y-13y 0.0-0.8 7y-13y 0.0-0.8
>14y 0.0-0.2 >14y 0.0-0.2
BM BAND FORMS % 0d 20.0-36.0 0d 20.0-36.0
1d-14d 20.0-36.0 1d-14d 20.0-36.0
15d-29d 3.1-25.1 15d-29d 3.1-25.1
1m-12m 3.1-25.1 1m-12m 3.1-25.1
12m-6y 9.4-15.4 12m-6y 9.4-15.4
7y-13y 9.4-15.4 7y-13y 9.4-15.4
>14y 9.4-15.4 >14y 9.4-15.4
BM NEUTROPHIL METAMYELOCYTES
% 0d 9.7-29.0 0d 9.7-29.0
1d-14d 3.5-19.6 1d-14d 3.5-19.6
15d-29d 3.5-19.6 15d-29d 3.5-19.6
1m-12m 3.5-19.6 1m-12m 3.5-19.6
12m-6y 3.5-20.7 12m-6y 3.5-20.7
7y-13y 3.5-20.7 7y-13y 3.5-20.7
>14y 7.1-24.7 >14y 7.1-24.7
BM NEUTROPHIL MYELOCYTES
% 0d 4.0-16.0 0d 4.0-16.0
1d-14d 4.0-16.0 1d-14d 4.0-16.0
15d-29d 4.0-16.0 15d-29d 4.0-16.0
1m-12m 4.0-16.0 1m-12m 4.0-16.0
12m-6y 4.0-16.0 12m-6y 4.0-16.0
7y-13y 4.0-16.0 7y-13y 4.0-16.0
>14y 8.5-16.9 >14y 8.5-16.9
BM EOSINOPHIL MYELOCYTES
% 0d 0.1-3.0 0d 0.1-3.0
1d-14d 0.1-3.0 1d-14d 0.1-3.0
15d-29d 0.1-3.0 15d-29d 0.1-3.0
1m-12m 0.1-3.0 1m-12m 0.1-3.0
12m-6y 0.1-3.0 12m-6y 0.1-3.0
7y-13y 0.1-3.0 7y-13y 0.1-3.0
>14y 0.1-3.0 >14y 0.1-3.0
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 31 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
BM PROMYELOCYTES % 0d 0.0-4.5 0d 0.0-4.5
1d-14d 0.0-4.5 1d-14d 0.0-4.5
15d-29d 0.0-4.5 15d-29d 0.0-4.5
1m-12m 0.0-4.5 1m-12m 0.0-4.5
12m-6y 0.0-4.5 12m-6y 0.0-4.5
7y-13y 0.5-4.5 7y-13y 0.5-4.5
>14y 1.9-4.7 >14y 1.9-4.7
BM BLASTS % 0d 0.0-4.0 0d 0.0-4.0
1d-14d 0.0-4.0 1d-14d 0.0-4.0
15d-29d 0.0-4.0 15d-29d 0.0-4.0
1m-12m 0.0-4.0 1m-12m 0.0-4.0
12m-6y 0.0-3.0 12m-6y 0.0-3.0
7y-13y 0.0-3.0 7y-13y 0.0-3.0
>14y 0.1-1.7 >14y 0.1-1.7
BM ORTHOCHROMIC NORMOBLASTS
% 0d 0.0-1.4 0d 0.0-1.4
1d-14d 0.0-1.4 1d-14d 0.0-1.4
15d-29d 0.0-1.4 15d-29d 0.0-1.4
1m-12m 0.0-1.6 1m-12m 0.0-1.6
12m-6y 0.0-1.6 12m-6y 0.0-1.6
7y-13y 0.0-1.6 7y-13y 0.0-1.6
>14y 0.3-4.6 >14y 0.3-4.6
BM POLYCHROMATIC NORMOBLASTS
% 0d 6.0-19.8 0d 6.0-19.8
1d-14d 6.0-19.8 1d-14d 6.0-19.8
15d-29d 6.0-19.8 15d-29d 6.0-19.8
1m-12m 2.0-16.0 1m-12m 2.0-16.0
12m-6y 2.0-16.0 12m-6y 2.0-16.0
7y-13y 2.0-16.0 7y-13y 2.0-16.0
>14y 13.1-30.1 >14y 13.1-30.1
BM BASOPHILIC NORMOBLASTS
% 0d 0.0-0.5 0d 0.0-0.5
1d-14d 0.0-0.5 1d-14d 0.0-0.5
15d-29d 0.0-0.5 15d-29d 0.0-0.5
1m-12m 0.0-1.0 1m-12m 0.0-1.0
12m-6y 0.0-1.0 12m-6y 0.0-1.0
7y-13y 0.0-1.0 7y-13y 0.0-1.0
>14y 0.4-2.4 >14y 0.4-2.4
BM PRONORMOBLASTS
% 0d 0.0-0.1 0d 0.0-0.1
1d-14d 0.0-0.1 1d-14d 0.0-0.1
15d-29d 0.0-0.1 15d-29d 0.0-0.1
1m-12m 0.0-0.3 1m-12m 0.0-0.3
12m-6y 0.0-0.3 12m-6y 0.0-0.3
7y-13y 0.0-0.3 7y-13y 0.0-0.3
>14y 0.1-1.3 >14y 0.1-1.3
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 32 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Test Unit Male Female Date
implemented Age/
parameter value Age/
parameter value
BM PLASMA CELLS % 0d 0.0-0.1 0d 0.0-0.1
1d-14d 0.0-0.1 1d-14d 0.0-0.1
15d-29d 0.0-0.1 15d-29d 0.0-0.1
1m-12m 0.0-0.1 1m-12m 0.0-0.1
12m-6y 0.0-0.1 12m-6y 0.0-0.1
7y-13y 0.0-0.1 7y-13y 0.0-0.1
>14y 0.0-3.9 >14y 0.0-3.9
BM ATYPICAL LYMPHOCYTES
% ALL 0.0-0.0 ALL 0.0-0.0
BM MEGAKARYOCYTES
% ALL 0.0-0.4 ALL 0.0-0.4
M:E RATIO ratio 0d 1.0-5.0 0d 1.0-5.0
1d-14d 1.0-5.0 1d-14d 1.0-5.0
15d-29d 1.0-5.0 15d-29d 1.0-5.0
1m-12m 2.5-10.0 1m-12m 2.5-10.0
12m-6y 2.5-8.0 12m-6y 2.5-8.0
7y-13y 2.5-8.0 7y-13y 2.5-8.0
>14y 1.1-3.5 >14y 1.1-3.5
COLD AGGLUTININS
TITRE ADULT RBC 37C titre ALL 0-1 ALL 0-1
TITRE ADULT RBC RT ALL 0-1 ALL 0-1
TITRE ADULT RBC 4C ALL 1-32 ALL 1-32
TITRE AUTOLOGOUS RBC 37C ALL 0-1 ALL 0-1
TITRE AUTOLOGOUS RBC RT
ALL 0-1 ALL 0-1
TITRE AUTOLOGOUS RBC 4C
ALL 1-32 ALL 1-32
TITRE CORD RBC 37C ALL 0-1 ALL 0-1
TITRE CORD RBC RT ALL 0-1 ALL 0-1
TITRE CORD RBC 4C ALL 0-8 ALL 0-8
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 33 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.
Immunology
Test Units Male Female Date implemented
Age/ parameter
value Age/ parameter
value
Anti Cardiolipin Antibodies - IgG
GPL N/A
1.0 – 9.0 (Negative)
N/A 1.0 – 9.0
(Negative)
Anti Cardiolipin Antibodies - IgM
MPL N/A
0.4 – 5.0 (Negative)
N/A 0.4 – 5.0
(Negative)
Anti Deamidated Gliadin Antibodies (DGP) - IgG
AU/mL
N/A <20 N/A <20
Anti Double Stranded DNA (dsDNA) Antibodies
IU/mL N/A 0-29 N/A 0-29
Anti Mitochondrial Antibodies
Titre N/A <20 N/A <20
Anti Myeloperoxidase (MPO-ANCA) Antibodies
RU/mL
N/A <20 N/A <20
Anti Nuclear Antibodies (ANA)
Titre N/A <160 N/A <160
Anti Phospholipase A2 Receptor (PLA2R) Antibodies
RU/mL
N/A <14 N/A <14
Anti Proteinase-3 (PR3-ANCA) Antibodies
RU/mL N/A <20 N/A <20
Anti Smooth Muscle Antibodies
Titre N/A <20 N/A <20
Anti Tissue Transglutaminase (tTG) Antibodies - IgA
AU/mL
N/A <20 N/A <20
Lymphocyte Subsets – CD3+ T-cells (#)
x10^6 cells/L ≥10y 688-2445 ≥10y 688-2445
Lymphocyte Subsets – CD3+ T-cells (%)
% ≥10y 59-84 ≥10y 59-84
Lymphocyte Subsets – CD3+/CD4+ T-cells (#)
x10^6 cells/L ≥10y 389-1569 ≥10y 389-1569
Lymphocyte Subsets – CD3+/CD4+ T-cells (%)
% ≥10y 31-59 ≥10y 31-59
Lymphocyte Subsets – CD3+/CD8+ T-cells (#)
x10^6 cells/L ≥10y 168-894 ≥10y 168-894
Lymphocyte Subsets – CD3+/CD8+ T-cells (%)
% ≥10y 12-42 ≥10y 12-42
Lymphocyte Subsets – CD19+ B-cells (#)
x10^6 cells/L ≥10y 98-597 ≥10y 98-597
PATHOLOGY REFERENCE INTERVAL MASTER LIST
Issue date: 9/10/2020 WIN-QS-19-2 Page 34 of 34
Monash Health Pathology
This is a controlled document of Monash Health Pathology. Uncontrolled copies of this document are valid only on the day of production.